Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia
Pre-publication versions of this article are available by contacting email@example.com.
|26 Sep 2018||Submitted||Original manuscript|
|3 Nov 2018||Reviewed||Reviewer Report - Susan - Branford|
|7 Jan 2019||Reviewed||Reviewer Report - Reviewer 2|
|22 Feb 2019||Author responded||Author comments - Graeme Greenfield|
|Resubmission - Version 2|
|22 Feb 2019||Submitted||Manuscript version 2|
|5 Mar 2019||Reviewed||Reviewer Report - Susan - Branford|
|22 Mar 2019||Author responded||Author comments - Graeme Greenfield|
|Resubmission - Version 3|
|22 Mar 2019||Submitted||Manuscript version 3|
|8 Apr 2019||Editorially accepted|
|2 May 2019||Article published||10.1186/s12878-019-0139-2|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.